Dr. Etan B. Spira, MD

Dr. Spira practices at Hudson Terrace Medical in Englewood Cliffs, New Jersey.

Dr. Spira's NPI, 1003011891, was assigned on June 20, 2007. Dr. Spira graduated from New York University School of Medicine in 2007. Dr. Spira holds New Jersey license 25MA09471300.

Dr. Spira's primary practice is Hudson Terrace Medical, at 464 Hudson Terrace, Englewood Cliffs, NJ 07632. The practice phone is (201) 503-0066.

Dr. Spira's primary practice is Hudson Terrace Medical in Englewood Cliffs, New Jersey. Dr. Spira is also affiliated with Jersey City Medical Center. The medical group on file is Hudson MD Group. Dmand AI also links Dr. Spira to 1 more hospital, 4 group practices and clinics and 3 medical groups, each named with a free account. Dr. Spira's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Spira practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Spira's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Spira is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Spira is licensed in New Jersey.

CMS data shows 355 Medicare services from Dr. Spira across 9 procedure codes in 2024, for 203 Medicare patients. Medicare paid $34,877 for them.

CMS counts 203 Medicare patients who saw Dr. Spira in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 41% are also on Medicaid. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Spira's median patient age at 62, with 58% women.

In 2024, Dr. Spira wrote 1,007 Medicare Part D claims for 320 patients. 77% of them were for generic drugs. CMS names the drug for 880 of them, across 21 drugs with 11 or more claims each, at $403,453 in total drug cost. In 2023, CMS named 868 claims across 19 drugs.

Dr. Spira accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 36 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Spira, more than 58% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Spira, published from 2022 to 2024. 2022 was the busiest year, with 2. Dr. Spira has published most often in Cureus. Dr. Spira's most frequent co-authors are Youssef Botros, William Ott, MD and Maria Elaine Szabela, MD.

Dmand AI links Dr. Spira to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 325 general payments to Dr. Spira from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 80% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,919.

Dr. Spira graduated from New York University School of Medicine in 2007.